Original articleThe new esters derivatives of betulin and betulinic acid in epidermoid squamous carcinoma treatment – In vitro studies
Introduction
The new anticancer agents and therapies are constantly searched. Researchers focus mainly on new applications of well-known drugs and also look for new, more efficient compounds with anti-tumor activity. Therefore, the development of novel and natural potent, non-toxic anticancer agents is worth a continuous effort. Natural substances derived mostly from plants provide an excellent platform for new drugs discovery. Herbal medicine based on drugs derived from plant in medicinal practice often becomes a kind of an alternative treatment [1], [2]. The majority of anticancer factor are of natural origin. The natural environment is a rich source of such materials which are currently used in oncology either in their intact/raw form, or as chemically modified derivatives (vinblastine, vincristine, paclitaxel, etoposide, teniposide) [3]. Moreover, it is known that natural products have been widely used for fighting human ailments [4], [5]. Recently, the researchers are interested in pentacyclic triterpens. These natural agents are formed by arrangement of squalene epoxide and are found in most plants. One of such compounds with promising anticancer activity are betulin (found mostly in the bark of the birch), betulinic acid (oxidation product of betulin) and their chemical derivatives [6], [7]. Previously reported in vitro and in vivo studies have demonstrated that these compounds have anti-tumor properties, and induce apoptosis in various tumor cells (human melanoma lines Mel-1, Mel-2, squamous carcinoma line A-431, cancer of the stomach sensitive and resistant to daunorubicin) [8], [9], [10], [11], [12].
Betulinic acid and betulin are triterpenes with documented cytotoxic properties against various cell lines [13]. Unfortunately both betulinic acid and its metabolic precursor, betulin, are very poorly soluble in aqueous buffers, thus their bioavailability and bio-distribution are insufficient in terms of medical applications. The newly synthesized betulin derivatives have a much better solubility in water while maintaining a high biological activity [11], [14]. In 2006, the action of triterpenes derived from bark of the birch on tumor squamous cell line A431 and also on normal human keratinocytes was described. The preliminary studies were performed in clinical trials in patients with a clinical diagnosis of actinic keratosis using the suspended in oil triterpenes extract [15]. Moreover, these compounds can induce apoptosis in cancer cells derived from keratinocytes. It was also demonstrated that betulin derivatives can stimulate differentiation in normal keratinocytes [16], [17]. Actinic keratosis (AK) is in the skin considered as precancerous lesion. These lesions are occurred in the skin damaged by the sun's rays. From the focal lesion can develop squamous cell carcinoma. The malignant neoplasm derived from keratinocytes can metastasize. Despite the raised frequency of skin cancer, the knowledge is still very poor and requires further research. The problem is very complex due to the trends in fashion for sunbathing, continues exposition on ultraviolet radiation, ozone depletion expanding and lengthening the survival of the population. Currently there are many applied treatments of AK, however none of them is sufficiently effective. The local formulations containing cytostatic (5-fluoroacyl) and immunomodulatory substances (imiquimed, diclofenac) are associated with large inflammatory reaction in the treated skin. Moreover, laser therapy and photodynamic therapy are very expensive methods, requiring specialized equipment and proper photosensitizers. Therefore, the new method and chemotherapeutics are needed for AK treatment. Recent studies showed the high efficiency in the AK treatment of the oil extract from triterpenes, derived from the birch bark. Moreover, the obtained results indicated very good skin tolerability [15], [17], [18].
Our research group derivatization of betulin from birch bark with selected natural amino acids (National patent application No PL211589 of 28.12.2011), which had better water solubility than betulin. We have also found, that new compounds have proapoptotic activity in cancer cells [11] what was has been also indicated in other studies [19], [20]. The purpose of our studies was to estimate the anticancer potency of new derivatives of betulin and betulinic acid in malignant cells derived from keratinocytes. The effect of those compounds will be also evaluated on model cells – normal human keratinocytes.
Section snippets
Cell culture
The human epidermal cancer cell line was used (A431), and normal keratinocytes (HaCaT) was use as a control. The epidermoid squamous carcinoma cell line A-431, derived from an 85-year-old female, is one of a series of cell lines established from solid tumors by D.J. Giard et al. [21]. The HaCaT cell line was a well-known immortalized human keratinocyte cell line, which was utilized for their high ability to proliferation and differentiation in vitro (ATCC) The cells were grown in DMEM (medium,
Survival assay
The highest cytotoxicity in cells skin cancer induced new compounds, particularly compound containing a lysine side chain (IC50 = 2.25 μM for 72 incubation hours and 7.28 for 48 h incubation) and ornithine (IC50 = 4.5 μM for 72 h incubation and 10 μM for 48 h incubation) in comparison to betulin and betulinic acid. For betulin-Dab-NH2, betulin-Dap-NH2l and betulin-Ala-NH2 the effect was significant only after 72 h incubation (Table 2). The enhanced antitumor activity was observed in the new betulin esters
Discussion
Multiple anti-precancerous lesion (actinic keratosis), basal skin cancers, derived from keratinocytes, therapies including surgical procedure, chemotherapy, photodynamic therapy have been developed. Some of them can cause side effects like baldness, immunodeficiency, organ damage and are not enough effective in skin cancer treatment [24], [25]. Majority type of cancer cells is resistant to apoptosis. In many cases malignant cells are characterized by mutation in genes responsible for this death
Conclusion
The results obtained in the current study indicate that new derivatives of betulin and betulinic acid can be effectively applied in human squamous cell lines. The most benefit is that the new compounds are safe for normal human keratinocytes. These findings demonstrate that new modified compounds derived from betulin have the high therapeutic potential in actinic keratosis.
Disclosure of interest
The authors declare that they have no conflicts of interest concerning this article.
Acknowledgments
The study was funded by the National Science Centre project number: 0275/B/P01/2010/38 (M. Drag-Zalesinska).
References (38)
- et al.
Plant-based anticancer molecules: a chemical and biological profile of some important leads
Bioorg. Med. Chem.
(2005) - et al.
Esters of betulin and betulinic acid with amino acids have improved water solubility and are selectively cytotoxic toward cancer cells
Bioorg. Med. Chem. Lett.
(2009) - et al.
Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells
Cancer Lett.
(2002) - et al.
Synthesis of betulinic acid derivatives with activity against human melanoma
Bioorg. Med. Chem. Lett.
(1998) - et al.
New ionic derivatives of betulinic acid as highly potent anti-cancer agents
Bioorg. Med. Chem. Lett.
(2012) - et al.
Sensitization for anticancer drug-induced apoptosis by betulinic acid
Neoplasia
(2005) - et al.
Recent advances in apoptosis, mitochondria and drug resistance in cancer cells
Biochim. Biophys. Acta
(2011) - et al.
New derivatives of lupine triterpenoids disturb breast cancer mitochondria and induce cell death
Bioorg. Med. Chem.
(2014) - et al.
The hallmark of cancer
Cell
(2000) - et al.
New betulinic acid derivatives as potent proteasome inhibitors
Bioorg. Med. Chem. Lett.
(2011)
Triterpenes promote keratinocyte differentiation in vitro, ex vivo and in vivo: a role for the transient receptor potential canonical (subtype) 6
J. Invest. Dermatol.
Anticancerous efficacy of betulinic acid: an immunomodulatory phytochemical
J. Pharm. Sci. Technol.
Betulinic acid: a new cytotoxic compound against malignant head and neck cancer cells
Head Neck
Natural products as sources of new drug over the period 1981–2002
J. Nat. Prod.
Natural products as sources of new drugs over the 30 years from 1981–2010
J. Nat. Prod.
The influence of natural products upon drug discovery
Nat. Prod. Rep.
Betulinic acid and its derivatives: a review on their biological properties
Curr. Med. Chem.
Comprehensive review on betulin as a potent anticancer agent
Biomed. Res. Int.
Triterpenes as potentially cytotoxic compounds
Molecules
Cited by (32)
Novel betulin derivatives inhibit IFN-γ and modulates COX-2 expression
2020, Natural Product ResearchDesign, synthesis and biological evaluation of betulin-3-yl 2-amino-2-deoxy-β-D-glycopyranosides
2020, Bioorganic ChemistryCitation Excerpt :As demonstrated by Jeong et al. [9], toxicity against the MEL-2 and KB cell lines of betulinic acid conjugates with various amino acids increases with water solubility. An increased water solubility was also reported by the Drąg group [10,11], who studied the esters of betulin with alanine, lysine, ornithine, 2,3-diaminopropane acid and 2,3-diaminobutane acid. Indeed, water solubility is an extremely important parameter deciding on the usefulness of a drug candidate.
Recent Developments on the Synthesis and Applications of Betulin and Betulinic Acid Derivatives as Therapeutic Agents
2017, Studies in Natural Products ChemistryCitation Excerpt :One of the significant challenges associated with the development of betulin analogs as therapeutic agents revolves around the limited solubility of these derivatives in aqueous media. Accordingly, several groups have tackled this problem via the derivatization of the alcohol group on C3 and/or the C28 primary alcohol position in betulin or the C28 acid moiety in betulinic acid as esters, amides, carbamates, ureas, hydroxamates, sulfates, sulfobetaines, phosphates, etc. [26–58]. Betulin and betulinic acid esters/amides have been very well studied, and several derivatives such as uracil esters, glyceryl esters, saponins, amino acid coupled amides, etc. have been synthesized to improve their solubility profile [3–12].